Rutan Woods, C. T., Makia, M. S., Lewis, T. R., Crane, R., Zeibak, S., Yu, P., … Al-Ubaidi, M. R. (2024). Author Correction: Downregulation of rhodopsin is an effective therapeutic strategy in ameliorating peripherin-2-associated inherited retinal disorders. Nat Commun, 15(1), 6091. https://doi.org/10.1038/s41467-024-50140-3

Rutan Woods, Christian T., Mustafa S. Makia, Tylor R. Lewis, Ryan Crane, Stephanie Zeibak, Paul Yu, Mashal Kakakhel, et al. “Author Correction: Downregulation of rhodopsin is an effective therapeutic strategy in ameliorating peripherin-2-associated inherited retinal disorders.” Nat Commun 15, no. 1 (July 19, 2024): 6091. https://doi.org/10.1038/s41467-024-50140-3.

Rutan Woods CT, Makia MS, Lewis TR, Crane R, Zeibak S, Yu P, et al. Author Correction: Downregulation of rhodopsin is an effective therapeutic strategy in ameliorating peripherin-2-associated inherited retinal disorders. Nat Commun. 2024 Jul 19;15(1):6091.

Rutan Woods, Christian T., et al. “Author Correction: Downregulation of rhodopsin is an effective therapeutic strategy in ameliorating peripherin-2-associated inherited retinal disorders.” Nat Commun, vol. 15, no. 1, July 2024, p. 6091. Pubmed, doi:10.1038/s41467-024-50140-3.

Rutan Woods CT, Makia MS, Lewis TR, Crane R, Zeibak S, Yu P, Kakakhel M, Castillo CM, Arshavsky VY, Naash MI, Al-Ubaidi MR. Author Correction: Downregulation of rhodopsin is an effective therapeutic strategy in ameliorating peripherin-2-associated inherited retinal disorders. Nat Commun. 2024 Jul 19;15(1):6091.